ReviewJournal of oncology2022

Efficacy and Safety of Nivolumab for Advanced Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Siqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.